पहचान

Bms-536924

सूचीबद्ध नहीं · C25H26ClN5O3

01पहचान

Lazychem IDLC-55086
CAS RNसूचीबद्ध नहीं
PubChem CID135440466
Molecular formulaC25H26ClN5O3
Molecular weight480.0 g/mol
IUPAC name4-[[(2S)-2-(3-chlorophenyl)-2-hydroxyethyl]amino]-3-(4-methyl-6-morpholin-4-yl-1H-benzimidazol-2-yl)-1H-pyridin-2-one
InChIKeyZWVZORIKUNOTCS-OAQYLSRUSA-N

02संरचना और त्रिविम रसायन

2D structurePubChem CID 135440466
Two-dimensional chemical structure of Bms-536924
Two-dimensional structure for the PubChem identity linked to this record. Confirm the identifiers before analytical use.

The parsed structure contains 5 rings, includes aromatic atoms, includes aliphatic carbon, has 1 defined stereocentre, contains at least one halogen atom. These statements are calculated from the published structure string.

Defined stereocentres1
Ring count5
Secondary amines1
Tertiary amines1
SMILESCC1=CC(=CC2=C1N=C(N2)C3=C(C=CNC3=O)NC[C@H](C4=CC(=CC=C4)Cl)O)N5CCOCC5
InChIसूचीबद्ध नहीं

03Stereochemistry

The published structure contains 1 defined and 0 unassigned tetrahedral stereocentre. The exact wedge and dash depiction is shown above.

Defined centres1Structure assigned
Unassigned centres0Structure unspecified
Assignment statusFully assignedExact published identity
Tetrahedral upper bound≤ 2Before symmetry reduction

Published same-connectivity configurations

1 record

These records have the same connectivity, molecular formula and protonation layer, but a different complete InChIKey stereochemical layer. Only separately structure-linked records are shown.

No additional structure-linked configuration with the same connectivity is currently present in the LazyChem dataset.

Scope: The mathematical 2^n value is only an upper bound. Symmetry and other stereogenic elements can change the number of distinct stereoisomers. A hypothetical configuration is not published as a compound record without a verified structure identity.

04भारत में स्थिति

Exact-compound status is evaluated only against the published name and CAS number. Confirm the current official instrument before a regulatory decision.

05नाम और संबंध

API और मूल औषधि

सूचीबद्ध नहीं

नाम और संबंध

    अशुद्धियाँ और संबंधित यौगिक

      06स्रोत